Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effectiveness of the Strain Lactobacillus Salivarius V4II-90 in the Reduction of Group B Streptococcus Colonization in Pregnant Women

NCT03669094 is registered in ClinicalTrials.gov with ProbiSearch SL as lead sponsor.

NCT NCT03669094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03669094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effectiveness of the Strain Lactobacillus Salivarius V4II-90 in the Reduction of Group B Streptococcus Colonization in Pregnant Women
Lead sponsor
ProbiSearch SL
Phase
Not applicable
Overall status
Completed
Start date
December 5, 2018
Completion date
October 4, 2021
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational mother, streptococcus agalactiae infection